Navigation Links
Vermillion to Discuss Preliminary Results for Fourth Quarter and Full Year 2012 on Wednesday, February 20, 2013, at 4:30 p.m. ET
Date:2/8/2013

AUSTIN, Texas, Feb. 8, 2013 /PRNewswire/ -- Vermillion, Inc. (NASDAQ: VRML), a molecular diagnostics company focused on gynecologic cancers and vascular medicine, will hold a conference call on Wednesday, February 20, 2013, at 4:30 p.m. ET to discuss preliminary results for its fourth quarter and full year 2012 ended December, 31, 2012. Select preliminary unaudited results will be issued in a press release prior to the call.

Vermillion's interim CEO Bruce A. Huebner will host the call, followed by a question and answer period.

Date: Wednesday, February 20, 2013 
Time: 4:30 p.m. Eastern time (1:30 p.m. Pacific time)
Dial-In Number: 1-800-909-4761
International: 1-212-231-2934
Conference ID#: 21648726
Webcast: http://edge.media-server.com/m/p/e247e2q2/lan/en

The conference call will be webcast live and available for replay via the investor section of the company's website at www.vermillion.com.

Please call the conference telephone number 5-10 minutes prior to the start time. An operator will register your name and organization. If you have any difficulty connecting with the conference call, please contact Liolios Group at 1-949-574-3860.

A replay of the call will be available approximately two hours after the call through March 6, 2013.

Toll-free replay number: 1-800-633-8284
International replay number: 1-402-977-9140
Replay pin number: 21648726

About Vermillion
Vermillion, Inc. (NASDAQ: VRML) is dedicated to the discovery, development and commercialization of novel high-value diagnostic tests that help physicians diagnose, treat and improve outcomes for patients. Vermillion, along with its prestigious scientific collaborators, has diagnostic programs in oncology, vascular medicine and women's health. Additional information about Vermillion can be found at www.vermillion.com.

Investor Relations Contact:
Liolios Group, Inc.
Ron Both 
Tel 1-949-574-3860
vrml@liolios.com


'/>"/>
SOURCE Vermillion, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Vermillion Sets First Quarter 2012 Conference Call for Tuesday, May 15, 2012 at 4:30 p.m. ET
2. Vermillion Announces CEO Succession Plan
3. Vermillion PAD Intended Use Study Presented at Society for Vascular Medicine 23rd Annual Scientific Sessions
4. Vermillion Announces Positive Top-Line Results from the OVA500 Multi-Center Study Led by UC Irvine
5. Vermillion Reports Second Quarter 2012 Results
6. Vermillion to Present at the 2012 Gateway Conference on September 6
7. Vermillion Sets Third Quarter 2012 Conference Call for Monday, November 12, 2012 at 4:30 p.m. ET
8. Vermillion Reports Third Quarter 2012 Results
9. Delaware Court of Chancery Dismisses Vermillion Dissident Shareholder Suit with Prejudice
10. Vermillion Appoints Bruce A. Huebner as Interim Chief Executive Officer
11. Gynecologic Oncology Publishes New Clinical Study Showing Positive Performance of OVA1, Vermillions Ovarian Cancer Test
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2020)... , ... July 31, 2020 , ... As one of ... has been providing residents of Missouri City, TX, with a wide range of professional ... 300, is a state-of-the-art dental facility that is not far from the previous clinic ...
(Date:7/22/2020)... ... July 22, 2020 , ... ... is proud to announce the addition of Moderna to its growing customer roster. ... on its technology for trial disclosure management, patient engagement and study recruitment. Collectively, ...
(Date:7/18/2020)... BOSTON (PRWEB) , ... July 17, 2020 , ... ... Journal of Consultation-Liaison Psychiatry uses case scenarios to illustrate how implicit bias among ... health care provided to sexual and gender minority people. The Perspective was authored ...
Breaking Medicine Technology:
(Date:8/11/2020)... ... August 11, 2020 , ... NeoTract, a wholly owned ... of urology, today announced that Sean Delair, M.D., Tennessee Urology in Powell, TN, ... Dr. Delair has achieved a high level of training and experience with the ...
(Date:8/7/2020)... ... 07, 2020 , ... As part of their efforts to prioritize the well-being ... Bengtson Center team decided to temporarily suspend most in-person appointments, with the exception of ... the offices now open again, the leading plastic surgeons in Michigan —Dr. Brad ...
(Date:8/7/2020)... ... August 07, 2020 , ... Mary J's Cannabis , Kingston’s premium ... dicentra Cannabis Consulting . , The store, which operates out of a ... first of many locations as the company plans to expand across Canada. , ...
(Date:8/5/2020)... ... 2020 , ... AdventHealth Carrollwood has partnered with Bayshore Christian School in Tampa ... 12, 2020. AdventHealth provided the school with key strategies and implementation plans to assist ... , “We are taking extra steps in our hospital and in our communities to ...
(Date:8/5/2020)... ... August 05, 2020 , ... ChronWell, ... as Director of Clinical Services and Myron Falchuk, M.D. as an Advisor, to ... “ChronWell has achieved incredible growth as demand for remote care management services soared ...
Breaking Medicine News(10 mins):